Cargando…

‘CROSS’-ing into the ‘Real World’: a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer

BACKGROUND: A standard of care for nonmetastatic esophageal cancer is trimodality therapy consisting of neoadjuvant chemoradiation and esophagectomy, with evidence for improved overall survival versus surgery alone in the ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS) tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higgins, Luke M., Lester-Coll, Nataniel H., Ades, Steven, Barry, Maura M., Borrazzo, Edward C., Ganguly, Eric K., Anker, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186498/ https://www.ncbi.nlm.nih.gov/pubmed/37201058 http://dx.doi.org/10.21037/jgo-22-633

Ejemplares similares

Trade-offs in sensitivity and sampling depth in bimodal atomic force microscopy and comparison to the trimodal case
por: Eslami, Babak, et al.
Publicado: (2014)

Rheological Behavior of DNP/HMX Melt-Cast Explosives with Bimodal and Trimodal Particle-Size Distributions
por: Xie, Hanfei, et al.
Publicado: (2023)

Assessment of a collaborative treatment model for trimodal management of esophageal cancer
por: Udelsman, Brooks V., et al.
Publicado: (2023)

Real-world implementation of diabetes management by pharmacists: The R(X)ING Practice Tool
por: Al Hamarneh, Yazid N., et al.
Publicado: (2021)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Radiation dose mapping and anastomotic complications after trimodality therapy for esophageal cancers
por: Bang, Andrew, et al.
Publicado: (2019)

Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2023)

Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer
por: Lester-Coll, Nataniel H., et al.
Publicado: (2021)

ASO Author Reflections: Predicting Early Recurrence After Trimodality Therapy for Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Trimodality Therapy vs Definitive Chemoradiation in Older Adults With Locally Advanced Esophageal Cancer
por: Gaber, Charles E, et al.
Publicado: (2022)

Personalized trimodal prehabilitation for gastrectomy
por: Bausys, Augustinas, et al.
Publicado: (2020)

Trimodality therapy for esophageal cancer: The role of surgical and radiation treatment parameters in the development of anastomotic complications
por: Alfaifi, Salem, et al.
Publicado: (2021)

Commentary: Adjuvant chemotherapy after trimodal therapy for esophageal carcinoma: A bitter pill to swallow
por: Du, Valerie X., et al.
Publicado: (2020)

Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma
por: Igbo, Benjamin Terfa, et al.
Publicado: (2022)

Archibald Inglis
Publicado: (1889)

Mallet-ing
Publicado: (1860)

Inge Borghuis
por: Kiers, Bart
Publicado: (2020)

Trimodal Therapy in Esophageal Squamous Cell Carcinoma: Role of Adjuvant Therapy Following Neoadjuvant Chemoradiation and Surgery
por: Li, Xiaokun, et al.
Publicado: (2022)

Prognostic factors associated with (18)FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
por: Feng, Wei-Hsiang, et al.
Publicado: (2022)

Trimodal therapy in squamous cell carcinoma of the esophagus
por: Matuschek, C, et al.
Publicado: (2011)

Bipolar disorder: Trimodal age‐at‐onset distribution
por: Bolton, Sorcha, et al.
Publicado: (2020)

Anaplastic thyroid cancer: outcomes of trimodal therapy
por: Houlihan, Orla A., et al.
Publicado: (2021)

Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer
por: Chen, Wan-Yu, et al.
Publicado: (2019)

Trimodal Therapy: A Tumor Vascular‐Targeted Interlocking Trimodal Nanosystem That Induces and Exploits Hypoxia (Adv. Sci. 8/2018)
por: Luan, Xin, et al.
Publicado: (2018)

Asymmetric Bimodal Exponential Power Distribution on the Real Line
por: Çankaya, Mehmet Niyazi
Publicado: (2018)

Inge J. Lissajoux
Publicado: (2016)

Orbit(ing) the furrow
por: Sreenivasan, Aparna
Publicado: (2004)

SNP'ing for longevity
por: Vijg, Jan
Publicado: (2009)

Check'-ing DLBCL
por: Salaverria, Itziar, et al.
Publicado: (2015)

Elsie Maud Inglis
por: Russell, Beatrice
Publicado: (1918)

David Wood Inglis
Publicado: (1934)

Professor Inglis of Aberdeen
Publicado: (1875)

Development of Rapid Response Plan for Radiation Oncology in Response to Cyberattack
por: Nelson, Carl J., et al.
Publicado: (2020)

Seq’ing identity and function in a repeat-derived noncoding RNA world
por: O’Neill, Rachel J.
Publicado: (2020)

Definitive re-irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance status
por: W. Kim, Daniel, et al.
Publicado: (2020)

Time to Surgery for Patients with Esophageal Cancer Undergoing Trimodal Therapy in Ontario: A Population-Based Cross-Sectional Study
por: Hanna, Nader M., et al.
Publicado: (2022)

Trimodality therapy in variant urothelial carcinoma: choose wisely
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2017)

Clinical outcomes of pancoast tumors treated with trimodality therapy
por: Lin, Tami Yu-Yu, et al.
Publicado: (2021)

Trimodality therapy of malignant pleural mesothelioma with helical tomotherapy
por: Ozyurt, Hazan, et al.
Publicado: (2023)

Megaripple mechanics: bimodal transport ingrained in bimodal sands
por: Tholen, Katharina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n4ve0ea5nj28la53skdn156qbf